肝肾综合征的治疗

蔡卫民; 张彬彬

肝肾综合征的治疗

详细信息

中图分类号: R5752
计量
- 文章访问数: 2034
- HTML全文浏览量: 3
- PDF下载量: 799
- 被引次数: 0
出版历程
- 出版日期: 2004-02-20

摘要

HTML全文

参考文献(17)

[1]EckardtKU .Renalfailureinliverdisease[J].IntensiveCareMed, 1999, 25∶5.

[2] WatanabeM , OzakiT , HirataY , etal.Mechanismforloweringbloodammonialevelsbylactitol[J].JpnJPharmacol, 1995, 4∶369-74.

[3] GinesP , GuevaraM .Goodnewsforhepatorenalsyndrome[J].Hepatolo gy, 2002, 36 (2) ∶504-506.

[4] AguillonD , SeguinP , MalledantY .Hepatorenalsyndrome:fromphys iopathologytotreatment[J].AnnFrAnesthReanim, 2003, 1∶30-8.

[5] LenzK , DrumlW , KleinbergerG , etal.Enhancementofrenalfunctionwithornipressininapatientwithdecompensatedcirrhosis[J].Gut, 1985, 26 (12) ∶1385-6.

[6] LenzK , HortnaglH , DrumlW , etal.Ornipressininthetreatmentoffunctionalrenalfailureindecompensatedelivercirrhosis[J].Gastroen terology, 1991, 101∶1060.

[7] GuevaraM , GinesP , FemrdezEG , etal.Reversibilityofhepatorenalsyndromebyprolongedadministrationofornipressinandplasmavolumeexpression[J].Hepatology, 1998, 27∶35.

[8] HadengueA , Gadao, GiostraE , etal.Terilpressininthetreatmentofhepatorenalsyndrome:Adoubleblindcrossoverstudy[J].Hepatology, 1995, 22 (A236) ∶165.

[9] HadengueA , GadanoA , MoreauR , etal.Beneficialeffectsofthe2daysadministrationofterlipressininpatientswithcirrhosisandhepatore nalsyndrome[J].JHepatol, 1998, 29∶565.

[10] OrtegaR , GinesP , UrizJ , etal.Terlipressintherapywithandwithoutalbuminforpatientswithhepatorentalsyndrome:resultsofaprospective, nonrandomizedstudy[J].Hepatology, 2002, 36 (4) ∶941-948.

[11] SolankiP , ChawlaA , GargR , etal.Beneficialeffectsofterlipressininhepatorenalsyndrome:aprospective, randomizedplacebo-controlledclinicaltrial[J].JGastroenterolHepatol, 2003, 18 (2) ∶152-6.

[12] KaffyF , BorderieC , ChagneauC , etal.Octreotideinthetreatmentofthehepatorenalsyndromeincirrhoticpatients[J].JHepatol, 1999, 30 (1) ∶174.

[13] AngeliP , VolpinR , GerundaG , etal.Reversaloftype1hepatorenalsyndromewiththeadministrationofmidodrineandoctreotide[J].Hepatol ogy, 1999, 29 (6) ∶1690-7.

[14] FeveryJ, Van-CutsemE , NevensF , etal.Reversalofhepatorenalsyndromeinfourpatientsbyperoralmisoprostol (prostaglandinE1ana logue) andalbuminadministration[J].JHepatol, 1990, 11 (2) ∶153-8.

[15] ClewellJD , Walker-RenardP .Prostaglandinsforthetreatmentofhepatorenalsyndrome[J].AnnPharmacother, 1994, 28 (1) ∶54-5.

[16] DuvouxC , ZanditenasD , HezodeC , etal.EffectsofnoradrenalinandalbumininpatientswithtypeⅠhepatorenalsyndrome:apilotstudy[J].2002, 36 (2) ∶374-380.

[17] CapellaGL .Anti-leukotrienedrugsinthepreventionandtreatmentofhepatorenalsyndrome[J].ProstaglandinsLeukotEssentFattyAcids, 2003, 68 (4) ∶263-5.

施引文献

资源附件(0)

访问统计